{
    "2019-09-18": [
        [
            {
                "time": "2018-09-18",
                "original_text": "格隆汇港股聚焦(9.18)︱通达集团拟分拆公司于深交所独立上市 四川成渝8月通行费收入升4.85%至4.07亿元",
                "features": {
                    "keywords": [
                        "通达集团",
                        "分拆",
                        "深交所",
                        "四川成渝",
                        "通行费收入"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "交通运输",
                        "基础设施"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-18",
                "original_text": "复星医药(02196.HK)：复宏汉霖H股发售价为每股49.6港元",
                "features": {
                    "keywords": [
                        "复星医药",
                        "复宏汉霖",
                        "H股",
                        "发售价"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-18",
                "original_text": "医疗保健：聚焦优质企业 荐12股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "优质企业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-18",
                "original_text": "一致性评价进入收获期，药品过评不断",
                "features": {
                    "keywords": [
                        "一致性评价",
                        "药品过评"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-18",
                "original_text": "IPO认购指南：复宏汉霖-B(2696.HK)",
                "features": {
                    "keywords": [
                        "IPO",
                        "复宏汉霖-B"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}